Abstract: This invention relates to an immunogen comprising a gonadotropin releasing hormone (GnRH) peptide sequence, a kisspeptin peptide sequence and a stimulant of raising an immune response, such an immunogen for use in a method to regulate the release of hormones in a vertebrate including modulation of reproductive hormones, to reduce fertility in a vertebrate and to treat hormone-dependent diseases including hormone-dependent tumours including prostate tumours, breast, ovary and endometrial tumours, benign hyperplasia including benign prostatic hyperplasia and uterine fibroids, endometriosis, polycystic ovarian disease, infertility, sexual dysfunction and any disorder that would benefit from an increased or decreased GnRH-dependent activity and a vaccine formulation comprising the immunogen. The invention also relates to the use of the immunogen in the preparation of a medicament for use in a method to regulate the release of hormones in a vertebrate.

Abstract: Methods of making hydrotreating catalysts are provided having one or more phosphorus components carried on a composite support of a titanium-loaded binder component and post-framework modified ultra-stable Y-type zeolite. The support comprises the titanium-loaded binder component and a post-framework modified ultra-stable Y-type (USY) zeolite. The active components including the phosphorous active component and one or more hydrocracking metals active components loaded on the support.

Abstract: A method for the preparation of a zeolite having MFI framework is provided that advantageously utilizes as a component oxidized disulfide oil, for example derived from a waste refinery stream of disulfide oil. The MFI framework zeolite is formed from an aqueous mixture of an aluminum source, a silica source, oxidized disulfide oil, an alkali metal source and a structure directing agent, which is heated under conditions and for a time effective to form the MFI framework zeolite.

Abstract: Systems and techniques are described herein for providing virtual content for a display. A method for providing virtual content for a display is provided. The method may include obtaining a plurality of images captured by a camera of a device, each image of the plurality of images including a respective representation of an object in an environment; predicting, based on the plurality of images, a pose of the object in a reference coordinate system associated with the environment; determining, based on the predicted pose of the object in the reference coordinate system, a pose of the object relative to the device; and providing, to a display of the device, virtual content based on the pose of the object relative to the device.

Abstract: Disclosed herein are modified zeolites and methods for making modified zeolites. In one or more embodiments disclosed herein, a zeolite may include a microporous framework comprising a plurality of micropores having diameters of less than or equal to 2 nm. The microporous framework may include at least silicon atoms and oxygen atoms. The modified zeolite may further include organometallic moieties each bonded to bridging oxygen atoms. The organometallic moieties may include a zirconium atom. The zirconium atom may be bonded to a bridging oxygen atom, and the bridging oxygen atom may bridge the zirconium atom of the organometallic moiety and a silicon atom of the microporous framework.

Abstract: The present disclosure is directed to a method to synthesize pure silica zeolites. This is accomplished by using an improved sol-gel formulation including a water-soluble fraction of ODSO as an additional component together with precursors and reagents effective for synthesis of pure silica zeolite.

Abstract: The present disclosure is directed to a method of manufacture of CHA framework crystalline materials of silica and a framework metal oxide, with the ability to reduce the amount of structure directing agent needed for synthesis. This is accomplished by using an improved sol-gel formulation including a water-soluble fraction of ODSO as an additional component. The resulting products include CHA framework crystalline materials of silica and a framework metal oxide, whereby a framework metal oxide can be an oxide of Al, Fe, B or Ga.

Abstract: The present disclosure is directed to a method of manufacture of zeolite. A sol-gel formulation includes a water-soluble fraction of ODSO as an additional component. The resulting products include zeolite with increased crystallinity relative to comparable sol-gel formulations without ODSO as a precursor. In additional embodiments, the rate of crystallization of the zeolite is greater relative to comparable sol-gel formulations without ODSO.

Abstract: The present disclosure is directed to a method of manufacture of CHA framework crystalline materials of silica and a framework metal oxide. This is accomplished by using an improved sol-gel formulation including a water-soluble fraction of ODSO as an additional component. The resulting products include CHA framework crystalline materials of silica and a framework metal oxide, whereby a framework metal oxide can be an oxide of Al, Fe, B or Ga, and yields can be increased relative to comparable sol-gel formulations without ODSO.

Abstract: Disclosed herein are modified zeolites and methods for making modified zeolites. In one or more embodiments disclosed herein, a modified zeolite may include a microporous framework comprising a plurality of micropores having diameters of less than or equal to 2 nm. The microporous framework may include at least silicon atoms and oxygen atoms. The modified zeolite may further include organometallic moieties each bonded to bridging oxygen atoms. The organometallic moieties may include a titanium atom. The titanium atom may be bonded to a bridging oxygen atom, and the bridging oxygen atom may bridge the titanium atom of the organometallic moiety and a silicon atom of the microporous framework.

Abstract: Catalyst particles comprising one or more active metal components and methods for manufacturing such catalyst particles are provided. The particles are a composite of a granulating agent or binder material such as an inorganic oxide, and an ultra-stable Y (hereafter “USY”) zeolite in which some of the aluminum atoms in the framework are substituted with zirconium atoms and/or titanium atoms and/or hafnium atoms. The one or more active phase components are incorporated prior to mixing the binder with the post-framework modified USY zeolite, extruding the resulting composite mixture, and forming the catalyst particles. The one or more active phase components are incorporated in the post-framework modified USY zeolite prior to forming the catalyst particles.

Abstract: Disclosed herein are modified zeolites and methods for making modified zeolites. In one or more embodiments disclosed herein, a modified zeolite includes a microporous framework including a plurality of micropores having diameters of less than or equal to 2 nm and organometallic moieties each bonded to bridging oxygen atoms. The microporous framework includes at least silicon atoms and oxygen atoms. The organometallic moieties include a metal atom and a ring structure including the metal atom, a nitrogen atom, and one or more carbon atoms. The metal atom may be bonded to a bridging oxygen atom, and wherein the bridging oxygen atom bridges the metal atom of the organometallic moiety and a silicon atom of the microporous framework.

Abstract: Catalyst particles comprising one or more active metal components and methods for manufacturing such catalyst particles are provided. The particles are a composite of a granulating agent or binder material such as an inorganic oxide, and an ultra-stable Y (hereafter “USY”) zeolite in which some of the aluminum atoms in the framework are substituted with zirconium atoms and/or titanium atoms and/or hafnium atoms. The one or more active phase components are incorporated prior to mixing the binder with the post-framework modified USY zeolite, extruding the resulting composite mixture, and forming the catalyst particles. The one or more active phase components are incorporated in the binder material prior to forming the catalyst particles.

Abstract: A method is provided for lowering blood sugar in a subject in need thereof by administering a dipeptidyl peptidase-4 inhibitor pharmaceutical composition to a subject qualified for over-the-counter access to the dipeptidyl peptidase-4 inhibitor pharmaceutical composition. In some embodiments, the dipeptidyl peptidase-4 inhibitor pharmaceutical composition includes saxagliptin, sitagliptin, linagliptin, alogliptin, or a pharmaceutically acceptable salt thereof. In some embodiments, the dipeptidyl peptidase-4 inhibitor pharmaceutical composition includes (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile or a pharmaceutically acceptable salt thereof.

Abstract: A method of making copper (I) 5-nitrotetrazolate (DBX-1) in isolated form comprising: a) reacting bis(ethylenediamine) copper (II) nitrotetrazolate with nitric acid or sulfuric acid to form a reaction product, subsequently b) reducing the reaction product of a) with ascorbate or ascorbic acid and reacting with copper chloride or copper sulfate to form copper (I) 5-nitrotetrazolate, and subsequently isolating the copper (I) 5-nitrotetrazolate (DBX-1) as a precipitate. The copper (I) 5-nitrotetrazolate produced by said method is useful as a primary explosive.

Abstract: The present disclosure is directed to a method to co-synthesize amorphous and crystalline porous materials, including a phase of crystalline solids possessing well-defined structures and uniform pore sizes, and an amorphous phase. A sol-gel formulation which includes a water-soluble fraction of ODSO as an additional component is provided that precipitates multiple solid phases.

Abstract: A functionalized fibrous hierarchical zeolite includes a framework comprising aluminum atoms, silicon atoms, and oxygen atoms, the framework further comprising a plurality of micropores and a plurality of mesopores. A plurality of nanoparticles comprising nickel are immobilized on the framework.

Abstract: The present disclosure is directed to methods of remediating contaminated soil. The methods may include mixing an oxidant, a catalyst, and optionally a phase transfer agent to form an oxidant mixture, applying the oxidant mixture onto the contaminated soil, washing the contaminated soil with a washing solution, inserting vacuum pipes into the contaminated soil, and vacuuming the contaminated soil to remove at least one of the oxidation mixture, contaminants, or oxidation products.

Abstract: Hydrotreating catalysts are provided having one or more phosphorus components carried on a composite support of a titanium-loaded binder component and post-framework modified ultra-stable Y-type zeolite. The support comprises the titanium-loaded binder component and a post-framework modified ultra-stable Y-type (USY) zeolite in which a portion of aluminum atoms constituting a zeolite framework thereof is substituted with zirconium atoms and/or titanium atoms and/or hafnium atoms. The active components including the phosphorous active component and one or more hydrocracking metals active components loaded on the support.

Abstract: Hydrotreating catalysts are provided having one or more phosphorus components carried on a composite support of a titanium-loaded binder component and post-framework modified ultra-stable Y-type zeolite. The support comprises the titanium-loaded binder component and a post-framework modified ultra-stable Y-type (USY) zeolite in which a portion of aluminum atoms constituting a zeolite framework thereof is substituted with zirconium atoms and/or titanium atoms and/or hafnium atoms. The active components including the phosphorous active component and one or more hydrocracking metals active components loaded on the support.